Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: mike head who wrote (7925)	12/2/1998 10:13:00 PM
From: Bluegreen	Respond to of 17367

Thanks, Mike. Murphy on his hotline tonight made the DSMB situation much clearer for me. Murphy even stated that he bought Xoma shares today! He also mentioned something about Jan. 15.<g> BTW,if move of domicile to Bermuda is approved, why in the world would the Lehman Bros agree to let Xoma pay them 500 grand in cash OR 500 grand worth of Xoma stock? Why wouldn't they just tell Xoma cash only?

To: mike head who wrote (7925)	12/3/1998 12:43:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Mike, once again thanks for the heads up. Just got to read the article, in Nature Biotechnology, and I was pleased with it. Guess, the market gets its' clues from other sources. <g> Some of it was new to me. Had seen some articles by Dr. Opal before but appreciated seeing his comments and noting that he is independent of the current trials. Girior quoted along with Dr. Scannon. Giroir: BPI is clearly the most effective endotoxin-neutralizing agent available.